<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="EN">
<head>
<meta name="viewport" content="width=840, height=1080"/>
<meta charset="utf-8"/>
<title>The Morphology of Human Blood Cells</title>
<link href="template.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<div>
<img class="stl_03" src="images/038.jpg" alt=""/>
<div class="layer">
<div class="stl_04 stl_05">
<div style="position:absolute; top:3.5724em; left:11.1458em;"><span class="stl_547 stl_31 stl_548" style="word-spacing:0.0081em;">Acute Myelogenous Leukemia &#160;</span></div>
<div style="position:absolute; top:2.9841em; left:7.8733em;"><span class="stl_549 stl_07 stl_73">2</span></div>
<div style="position:absolute; top:2.9065em; left:5.8333em;"><span class="stl_549 stl_07 stl_73">1</span></div>
<div style="position:absolute; top:11.6667em; left:6.75em;"><span class="stl_550 stl_07 stl_136" style="word-spacing:0.1017em;">Acute myelogenous leukemia (AML) is a malignant clonal &#160;</span></div>
<div style="position:absolute; top:12.6663em; left:6.75em;"><span class="stl_550 stl_07 stl_87" style="word-spacing:-0.0039em;">disorder characterized by discordance between proliferation &#160;</span></div>
<div style="position:absolute; top:13.6659em; left:6.75em;"><span class="stl_550 stl_07 stl_68" style="word-spacing:-0.0302em;">and differentiation: the leukemic cell lineage retains the abil- &#160;</span></div>
<div style="position:absolute; top:14.6655em; left:6.75em;"><span class="stl_550 stl_07 stl_87" style="word-spacing:0.0641em;">ity to proliferate but differentiation to mature cells is com- &#160;</span></div>
<div style="position:absolute; top:15.6651em; left:6.75em;"><span class="stl_550 stl_07 stl_16" style="word-spacing:-0.0213em;">promised. The</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.0087em;"> result is excessive accumulation of</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.0377em;"> immature &#160;</span></div>
<div style="position:absolute; top:16.6647em; left:6.75em;"><span class="stl_550 stl_07 stl_73" style="word-spacing:0.2261em;">cells and inhibition of</span><span class="stl_550 stl_07 stl_73" style="word-spacing:0.2551em;"> well</span><span class="stl_550 stl_07 stl_73" style="word-spacing:0.2261em;"> differentiated</span><span class="stl_550 stl_07 stl_73" style="word-spacing:0.2261em;"> hematopoietic &#160;</span></div>
<div style="position:absolute; top:17.6643em; left:6.75em;"><span class="stl_550 stl_07 stl_221" style="word-spacing:0.1562em;">elements. Exposure</span><span class="stl_550 stl_07 stl_221" style="word-spacing:0.1852em;"> to radiation,</span><span class="stl_550 stl_07 stl_221" style="word-spacing:0.1562em;"> hydrocarbons,</span><span class="stl_550 stl_07 stl_221" style="word-spacing:0.1562em;"> and &#160;</span></div>
<div style="position:absolute; top:18.6639em; left:6.75em;"><span class="stl_550 stl_07 stl_83" style="word-spacing:0.2265em;">chemotherapeutic agents appears to increase the risk of &#160;</span></div>
<div style="position:absolute; top:19.6635em; left:6.75em;"><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0204em;">AML. Several</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0504em;"> genetic abnormalities including mutations</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0504em;"> in &#160;</span></div>
<div style="position:absolute; top:20.6631em; left:6.75em;"><span class="stl_550 stl_07 stl_69" style="word-spacing:0.1233em;">growth factor receptors and defects in the normal control &#160;</span></div>
<div style="position:absolute; top:21.6627em; left:6.75em;"><span class="stl_550 stl_07 stl_44" style="word-spacing:-0.0067em;">mechanisms of</span><span class="stl_550 stl_07 stl_44" style="word-spacing:0.0233em;"> the</span><span class="stl_550 stl_07 stl_44" style="word-spacing:-0.0067em;"> cell cycle have been described in</span><span class="stl_550 stl_07 stl_44" style="word-spacing:-0.0067em;"> patients &#160;</span></div>
<div style="position:absolute; top:22.6622em; left:6.75em;"><span class="stl_550 stl_07 stl_24" style="word-spacing:0.0013em;">with acute leukemia. &#160;</span></div>
<div style="position:absolute; top:11.594em; left:28em;"><span class="stl_551 stl_171 stl_393" style="word-spacing:0.0139em;">Laboratory Findings &#160;</span></div>
<div style="position:absolute; top:13.3668em; left:28em;"><span class="stl_550 stl_07 stl_35" style="word-spacing:0.2205em;">The diagnosis of</span><span class="stl_550 stl_07 stl_35" style="word-spacing:0.2495em;"> acute</span><span class="stl_550 stl_07 stl_35" style="word-spacing:0.2205em;"> leukemia becomes apparent</span><span class="stl_550 stl_07 stl_35" style="word-spacing:0.2205em;"> after &#160;</span></div>
<div style="position:absolute; top:14.3664em; left:28em;"><span class="stl_550 stl_07 stl_35" style="word-spacing:-0.045em;">evaluating the patient and examining the blood smear. Blasts &#160;</span></div>
<div style="position:absolute; top:15.366em; left:28em;"><span class="stl_550 stl_07 stl_61" style="word-spacing:0.2173em;">or immature cells are usually present in the majority of &#160;</span></div>
<div style="position:absolute; top:16.3656em; left:28em;"><span class="stl_550 stl_07 stl_40" style="word-spacing:-0.0146em;">patients with AML, but in a very few patients, no circulating &#160;</span></div>
<div style="position:absolute; top:17.3652em; left:28em;"><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1032em;">blast cells can be found.</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0732em;"> The</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1032em;"> presence of</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1322em;"> an</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0842em;"> Auer</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1032em;"> rod in</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1032em;"> a &#160;</span></div>
<div style="position:absolute; top:18.3648em; left:28em;"><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0952em;">blast aids in the diagnosis of</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.1042em;"> AML.</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0642em;"> Multiple</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0752em;"> Auer</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0952em;"> rods</span><span class="stl_550 stl_07 stl_99" style="word-spacing:0.0952em;"> are &#160;</span></div>
<div style="position:absolute; top:19.3644em; left:28em;"><span class="stl_550 stl_07 stl_138" style="word-spacing:0.0927em;">observed in a few early cells in</span><span class="stl_550 stl_07 stl_138" style="word-spacing:0.0727em;"> AML</span><span class="stl_550 stl_07 stl_138" style="word-spacing:0.0927em;"> M3 (</span><span class="stl_552 stl_07 stl_41" style="word-spacing:0.1013em;">PLATE</span><span class="stl_550 stl_07 stl_138" style="word-spacing:0.1319em;"> 47).</span><span class="stl_550 stl_07 stl_138" style="word-spacing:0.0627em;"> The &#160;</span></div>
<div style="position:absolute; top:20.3664em; left:28.0003em;"><span class="stl_550 stl_07 stl_81" style="word-spacing:0.1559em;">diagnosis of AML is established when more than 30% of &#160;</span></div>
<div style="position:absolute; top:21.366em; left:28.0003em;"><span class="stl_550 stl_07 stl_41" style="word-spacing:0.1589em;">nonerythroid cells in the marrow are myeloid blasts.</span><span class="stl_550 stl_07 stl_41" style="word-spacing:0.1289em;"> The &#160;</span></div>
<div style="position:absolute; top:22.3656em; left:28.0003em;"><span class="stl_550 stl_07 stl_76" style="word-spacing:0.0417em;">bone marrow in acute leukemia is typically hypercellular.</span><span class="stl_550 stl_07 stl_76" style="word-spacing:0.0117em;"> It &#160;</span></div>
<div style="position:absolute; top:23.3652em; left:28.0003em;"><span class="stl_550 stl_07 stl_15" style="word-spacing:-0.0375em;">is essential to obtain enough material from the bone marrow &#160;</span></div>
<div style="position:absolute; top:24.3648em; left:28.0003em;"><span class="stl_550 stl_07 stl_122" style="word-spacing:-0.0007em;">for cytogenetic analysis and flow cytometric studies. &#160;</span></div>
<div style="position:absolute; top:24.7271em; left:6.75em;"><span class="stl_551 stl_171 stl_131" style="word-spacing:0.0243em;">The FAB Classification of</span><span class="stl_551 stl_171 stl_131" style="word-spacing:0.0333em;"> AML &#160;</span></div>
<div style="position:absolute; top:25.3644em; left:29.5006em;"><span class="stl_550 stl_07 stl_412" style="word-spacing:0.6149em;">The most important cytogenetic abnormalities &#160;</span></div>
<div style="position:absolute; top:26.364em; left:28.0003em;"><span class="stl_550 stl_07 stl_38" style="word-spacing:0.1985em;">observed in patients with</span><span class="stl_550 stl_07 stl_38" style="word-spacing:0.1937em;"> AML include translocations</span><span class="stl_550 stl_07 stl_38" style="word-spacing:0.1937em;"> of &#160;</span></div>
<div style="position:absolute; top:27.3636em; left:28.0003em;"><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0543em;">chromosomes 8,</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0253em;"> 11</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0543em;"> in M2;</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0453em;"> 15,</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0253em;"> 17</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0543em;"> in patients with M3;</span><span class="stl_550 stl_07 stl_39" style="word-spacing:0.0453em;"> and &#160;</span></div>
<div style="position:absolute; top:28.3632em; left:28.0003em;"><span class="stl_550 stl_07 stl_42" style="word-spacing:0.0258em;">inversion of</span><span class="stl_550 stl_07 stl_42" style="word-spacing:0.0548em;"> chromosome</span><span class="stl_550 stl_07 stl_42" style="word-spacing:0.0258em;"> 16 in M4 with</span><span class="stl_550 stl_07 stl_42" style="word-spacing:0.0258em;"> eosinophils. &#160;</span></div>
<div style="position:absolute; top:29.3628em; left:29.5006em;"><span class="stl_550 stl_07 stl_126" style="word-spacing:-0.0049em;">The evaluation of the patient with AML should include &#160;</span></div>
<div style="position:absolute; top:30.3624em; left:28.0003em;"><span class="stl_550 stl_07 stl_21" style="word-spacing:-0.0047em;">screening coagulation tests, fibrinogen, and D-dimer to rule &#160;</span></div>
<div style="position:absolute; top:31.362em; left:28.0003em;"><span class="stl_550 stl_07 stl_87" style="word-spacing:0.1211em;">out the presence of</span><span class="stl_550 stl_07 stl_87" style="word-spacing:0.1501em;"> DIC.</span><span class="stl_550 stl_07 stl_87" style="word-spacing:0.0711em;"> Appropriate</span><span class="stl_550 stl_07 stl_87" style="word-spacing:0.1211em;"> measures should</span><span class="stl_550 stl_07 stl_87" style="word-spacing:0.1211em;"> be &#160;</span></div>
<div style="position:absolute; top:32.3616em; left:28.0003em;"><span class="stl_550 stl_07 stl_44" style="word-spacing:0.2542em;">taken to manage these patients since chemotherapy can &#160;</span></div>
<div style="position:absolute; top:33.3612em; left:28.0003em;"><span class="stl_550 stl_07 stl_23" style="word-spacing:0.0302em;">exacerbate DIC,</span><span class="stl_550 stl_07 stl_23" style="word-spacing:0.0012em;"> leading</span><span class="stl_550 stl_07 stl_23" style="word-spacing:0.0302em;"> to excessive</span><span class="stl_550 stl_07 stl_23" style="word-spacing:0.0302em;"> morbidity. &#160;</span></div>
<div style="position:absolute; top:26.5em; left:6.75em;"><span class="stl_550 stl_07 stl_553" style="word-spacing:0.2184em;">Acute myelogenous leukemia is a heterogeneous group of &#160;</span></div>
<div style="position:absolute; top:27.4996em; left:6.75em;"><span class="stl_550 stl_07 stl_22" style="word-spacing:0.0412em;">hematologic malignancies that are classified according to the &#160;</span></div>
<div style="position:absolute; top:28.4992em; left:6.75em;"><span class="stl_550 stl_07 stl_29" style="word-spacing:0.3322em;">predominant malignant cell type.</span><span class="stl_550 stl_07 stl_29" style="word-spacing:0.3167em;"> In 1976, the</span><span class="stl_550 stl_07 stl_29" style="word-spacing:0.3167em;"> French &#160;</span></div>
<div style="position:absolute; top:29.4988em; left:6.75em;"><span class="stl_550 stl_07 stl_554" style="word-spacing:-0.0072em;">American British (FAB) Cooperative Group developed a clas- &#160;</span></div>
<div style="position:absolute; top:30.4984em; left:6.75em;"><span class="stl_550 stl_07 stl_555" style="word-spacing:0.1113em;">sification system (</span><span class="stl_552 stl_07 stl_556" style="word-spacing:0.1217em;">TABLE</span><span class="stl_550 stl_07 stl_555" style="word-spacing:0.1305em;"> 5)</span><span class="stl_550 stl_07 stl_555" style="word-spacing:0.1123em;"> that was based on marrow</span><span class="stl_550 stl_07 stl_555" style="word-spacing:0.1123em;"> and &#160;</span></div>
<div style="position:absolute; top:31.4996em; left:6.7501em;"><span class="stl_550 stl_07 stl_557" style="word-spacing:0.3429em;">blood morphology and cytochemical staining.</span><span class="stl_550 stl_07 stl_557" style="word-spacing:0.3129em;"> Immuno- &#160;</span></div>
<div style="position:absolute; top:32.4992em; left:6.7501em;"><span class="stl_550 stl_07 stl_558" style="word-spacing:-0.0049em;">phenotypic markers of</span><span class="stl_550 stl_07 stl_558" style="word-spacing:0.0251em;"> leukemic</span><span class="stl_550 stl_07 stl_558" style="word-spacing:-0.0049em;"> cells (phenotyping) are</span><span class="stl_550 stl_07 stl_558" style="word-spacing:-0.0049em;"> used &#160;</span></div>
<div style="position:absolute; top:33.4988em; left:6.7501em;"><span class="stl_550 stl_07 stl_355" style="word-spacing:0.3274em;">to establish the lineage in cases of</span><span class="stl_550 stl_07 stl_355" style="word-spacing:0.3424em;"> poorly</span><span class="stl_550 stl_07 stl_355" style="word-spacing:0.3424em;"> differentiated &#160;</span></div>
<div style="position:absolute; top:34.4984em; left:6.7501em;"><span class="stl_550 stl_07 stl_559" style="word-spacing:-0.0031em;">leukemias. The FAB classification defines groups (M1-M7) of &#160;</span></div>
<div style="position:absolute; top:35.498em; left:6.7501em;"><span class="stl_550 stl_07 stl_560" style="word-spacing:0.0959em;">AML based on the percentage of</span><span class="stl_550 stl_07 stl_560" style="word-spacing:0.1249em;"> maturing</span><span class="stl_550 stl_07 stl_560" style="word-spacing:0.0959em;"> cells beyond</span><span class="stl_550 stl_07 stl_560" style="word-spacing:0.0959em;"> the &#160;</span></div>
<div style="position:absolute; top:36.4976em; left:6.7501em;"><span class="stl_550 stl_07 stl_509" style="word-spacing:-0.0036em;">myeloblast stage. The FAB classification did not include crite- &#160;</span></div>
<div style="position:absolute; top:37.4972em; left:6.7501em;"><span class="stl_550 stl_07 stl_561" style="word-spacing:0.1895em;">ria such as cytogenetic abnormalities,</span><span class="stl_550 stl_07 stl_561" style="word-spacing:0.1605em;"> response</span><span class="stl_550 stl_07 stl_561" style="word-spacing:0.1895em;"> to</span><span class="stl_550 stl_07 stl_561" style="word-spacing:0.1895em;"> therapy, &#160;</span></div>
<div style="position:absolute; top:38.4968em; left:6.7501em;"><span class="stl_550 stl_07 stl_562" style="word-spacing:0.0455em;">and prognosis.</span><span class="stl_550 stl_07 stl_562" style="word-spacing:0.0145em;"> However, it</span><span class="stl_550 stl_07 stl_562" style="word-spacing:0.0455em;"> remains the most accepted</span><span class="stl_550 stl_07 stl_562" style="word-spacing:0.0455em;"> classi- &#160;</span></div>
<div style="position:absolute; top:39.4964em; left:6.7501em;"><span class="stl_550 stl_07 stl_563" style="word-spacing:0.0275em;">fication system of</span><span class="stl_550 stl_07 stl_563" style="word-spacing:0.0565em;"> acute</span><span class="stl_550 stl_07 stl_563" style="word-spacing:0.0275em;"> myelogenous</span><span class="stl_550 stl_07 stl_563" style="word-spacing:0.0275em;"> leukemias. &#160;</span></div>
<div style="position:absolute; top:34.3608em; left:29.5006em;"><span class="stl_550 stl_07 stl_36" style="word-spacing:-0.0101em;">It is important to perform histochemical stains in every &#160;</span></div>
<div style="position:absolute; top:35.3604em; left:28.0003em;"><span class="stl_550 stl_07 stl_37" style="word-spacing:0.0342em;">patient being evaluated for acute leukemia.</span><span class="stl_550 stl_07 stl_37" style="word-spacing:0.0042em;"> The</span><span class="stl_550 stl_07 stl_37" style="word-spacing:0.0342em;"> majority</span><span class="stl_550 stl_07 stl_37" style="word-spacing:0.0342em;"> of &#160;</span></div>
<div style="position:absolute; top:36.36em; left:28.0003em;"><span class="stl_550 stl_07 stl_173" style="word-spacing:0.0103em;">AML blasts stain positively (</span><span class="stl_552 stl_07 stl_65" style="word-spacing:0.0112em;">PLATE</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.031em;"> 48)</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.0113em;"> for</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.0113em;"> myeloperoxidase &#160;</span></div>
<div style="position:absolute; top:37.3664em; left:27.9996em;"><span class="stl_550 stl_07 stl_122" style="word-spacing:-0.0044em;">(MPO), while as a general rule, lymphoblasts are MPO neg- &#160;</span></div>
<div style="position:absolute; top:38.366em; left:27.9996em;"><span class="stl_550 stl_07 stl_35" style="word-spacing:0.3486em;">ative but stain positively for terminal deoxynucleotidyl &#160;</span></div>
<div style="position:absolute; top:39.3656em; left:27.9996em;"><span class="stl_550 stl_07 stl_564" style="word-spacing:0.3688em;">transferase (TdT). Other stains used to</span><span class="stl_550 stl_07 stl_564" style="word-spacing:0.3688em;"> differentiate &#160;</span></div>
<div style="position:absolute; top:40.3652em; left:27.9996em;"><span class="stl_550 stl_07 stl_42" style="word-spacing:0.2388em;">myeloblasts from lymphoblasts are the Sudan black and &#160;</span></div>
<div style="position:absolute; top:41.3648em; left:27.9996em;"><span class="stl_550 stl_07 stl_80" style="word-spacing:0.2111em;">esterase stains.</span><span class="stl_550 stl_07 stl_80" style="word-spacing:0.1811em;"> Sudan</span><span class="stl_550 stl_07 stl_80" style="word-spacing:0.2111em;"> black (</span><span class="stl_552 stl_07 stl_115" style="word-spacing:0.2307em;">PLATE</span><span class="stl_550 stl_07 stl_80" style="word-spacing:0.2179em;"> 48) and</span><span class="stl_550 stl_07 stl_80" style="word-spacing:0.2179em;"> granulocyte &#160;</span></div>
<div style="position:absolute; top:42.3664em; left:28.0002em;"><span class="stl_550 stl_07 stl_67" style="word-spacing:0.0601em;">esterase stains are positive in M1 through M4 and negative &#160;</span></div>
<div style="position:absolute; top:41.5605em; left:6.75em;"><span class="stl_551 stl_171 stl_67" style="word-spacing:0.0221em;">Presentation of</span><span class="stl_551 stl_171 stl_67" style="word-spacing:0.0331em;"> AML &#160;</span></div>
<div style="position:absolute; top:43.3333em; left:6.75em;"><span class="stl_550 stl_07 stl_111" style="word-spacing:0.1166em;">All leukemia subtypes share similar clinical characteristics. &#160;</span></div>
<div style="position:absolute; top:44.3329em; left:6.75em;"><span class="stl_550 stl_07 stl_95" style="word-spacing:0.1274em;">However, certain</span><span class="stl_550 stl_07 stl_95" style="word-spacing:0.1574em;"> features such as involvement of</span><span class="stl_550 stl_07 stl_95" style="word-spacing:0.1864em;"> the</span><span class="stl_550 stl_07 stl_95" style="word-spacing:0.1574em;"> skin &#160;</span></div>
<div style="position:absolute; top:45.3325em; left:6.75em;"><span class="stl_550 stl_07 stl_64" style="word-spacing:0.0913em;">and gums are more common in the M4 and M5 subtypes. &#160;</span></div>
<div style="position:absolute; top:46.3321em; left:6.75em;"><span class="stl_550 stl_07 stl_75" style="word-spacing:0.0149em;">Similarly, disseminated</span><span class="stl_550 stl_07 stl_75" style="word-spacing:0.0449em;"> intravascular coagulation (DIC) is</span><span class="stl_550 stl_07 stl_75" style="word-spacing:0.0449em;"> a &#160;</span></div>
<div style="position:absolute; top:47.3317em; left:6.75em;"><span class="stl_550 stl_07 stl_52" style="word-spacing:-0.0274em;">constant feature of M3, but can occur in any variant of AML. &#160;</span></div>
<div style="position:absolute; top:48.3313em; left:6.75em;"><span class="stl_550 stl_07 stl_16" style="word-spacing:0.2485em;">Presenting symptoms of AML include fatigue,</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.2157em;"> weakness, &#160;</span></div>
<div style="position:absolute; top:49.3309em; left:6.75em;"><span class="stl_550 stl_07 stl_173" style="word-spacing:0.2612em;">fever, weight</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.2912em;"> loss,</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.2612em;"> petechiae, and</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.2912em;"> easy bruising.</span><span class="stl_550 stl_07 stl_173" style="word-spacing:0.2612em;"> Physical &#160;</span></div>
<div style="position:absolute; top:50.3305em; left:6.75em;"><span class="stl_550 stl_07 stl_292" style="word-spacing:0.0624em;">examination usually reveals pallor,</span><span class="stl_550 stl_07 stl_292" style="word-spacing:0.0324em;"> tachycardia,</span><span class="stl_550 stl_07 stl_292" style="word-spacing:0.0324em;"> ecchymosis, &#160;</span></div>
<div style="position:absolute; top:51.3301em; left:6.75em;"><span class="stl_550 stl_07 stl_115" style="word-spacing:0.0084em;">and petechiae. The spleen may be palpable in a few patients. &#160;</span></div>
<div style="position:absolute; top:52.3297em; left:6.75em;"><span class="stl_550 stl_07 stl_115" style="word-spacing:0.1735em;">Cutaneous leukemia infiltrates the gums,</span><span class="stl_550 stl_07 stl_115" style="word-spacing:0.1425em;"> causing</span><span class="stl_550 stl_07 stl_115" style="word-spacing:0.1735em;"> gingival &#160;</span></div>
<div style="position:absolute; top:53.3293em; left:6.75em;"><span class="stl_550 stl_07 stl_187" style="word-spacing:0.1845em;">hyperplasia and signs of</span><span class="stl_550 stl_07 stl_187" style="word-spacing:0.2136em;"> leptomeningeal</span><span class="stl_550 stl_07 stl_187" style="word-spacing:0.1846em;"> leukemia can</span><span class="stl_550 stl_07 stl_187" style="word-spacing:0.1846em;"> be &#160;</span></div>
<div style="position:absolute; top:54.3289em; left:6.75em;"><span class="stl_550 stl_07 stl_16" style="word-spacing:0.1445em;">seen in some patients.</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.0935em;"> Anemia</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.1445em;"> and thrombocytopenia</span><span class="stl_550 stl_07 stl_16" style="word-spacing:0.1445em;"> are &#160;</span></div>
<div style="position:absolute; top:55.3285em; left:6.75em;"><span class="stl_550 stl_07 stl_65" style="word-spacing:0.1474em;">constant features of AML.</span><span class="stl_550 stl_07 stl_65" style="word-spacing:0.0951em;"> Approximately</span><span class="stl_550 stl_07 stl_65" style="word-spacing:0.1441em;"> 50% of</span><span class="stl_550 stl_07 stl_65" style="word-spacing:0.1741em;"> patients &#160;</span></div>
<div style="position:absolute; top:56.3281em; left:6.75em;"><span class="stl_550 stl_07 stl_115" style="word-spacing:0.0067em;">with AML present with high white cell counts. The presence &#160;</span></div>
<div style="position:absolute; top:45.5921em; left:28em;"><span class="stl_565 stl_89 stl_172" style="word-spacing:0.0008em;">Table 5. Morphologic (FAB) Classification &#160;</span></div>
<div style="position:absolute; top:46.5086em; left:28em;"><span class="stl_565 stl_89 stl_41" style="word-spacing:-0.0001em;">of Acute Myelogenous Leukemia (AML) &#160;</span></div>
<div style="position:absolute; top:48.2763em; left:28em;"><span class="stl_566 stl_166 stl_65">SUBTYPE &#160;</span></div>
<div style="position:absolute; top:48.2763em; left:33.25em;"><span class="stl_566 stl_166 stl_65">DESCRIPTION &#160;</span></div>
<div style="position:absolute; top:49.3198em; left:28em;"><span class="stl_567 stl_169 stl_36">Ml: &#160;</span></div>
<div style="position:absolute; top:49.3198em; left:31.286em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">Acute myeloblastic leukemia without maturation &#160;</span></div>
<div style="position:absolute; top:50.3199em; left:31.2867em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">(Plate 47) &#160;</span></div>
<div style="position:absolute; top:51.4866em; left:28em;"><span class="stl_567 stl_169 stl_36">M2: &#160;</span></div>
<div style="position:absolute; top:51.4866em; left:31.281em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.0627em;">Acute myeloblastic leukemia with maturation (Plate 47) &#160;</span></div>
<div style="position:absolute; top:52.6532em; left:31.286em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">Acute promyelocytic leukemia (Plate 47) &#160;</span></div>
<div style="position:absolute; top:52.6532em; left:28em;"><span class="stl_567 stl_169 stl_36">M3: &#160;</span></div>
<div style="position:absolute; top:53.8198em; left:28em;"><span class="stl_567 stl_169 stl_36">M4: &#160;</span></div>
<div style="position:absolute; top:53.8198em; left:31.286em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">Acute myelomonocytic leukemia (Plate 49) &#160;</span></div>
<div style="position:absolute; top:54.9864em; left:31.281em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">Acute myelomonocytic leukemia with eosinophilia &#160;</span></div>
<div style="position:absolute; top:56.1531em; left:31.286em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">Acute monocytic leukemia (Plates</span><span class="stl_567 stl_169 stl_36" style="word-spacing:0.095em;"> 49,</span><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;"> 50) &#160;</span></div>
<div style="position:absolute; top:54.9864em; left:28em;"><span class="stl_567 stl_169 stl_36">M4EO: &#160;</span></div>
<div style="position:absolute; top:56.1531em; left:28em;"><span class="stl_567 stl_169 stl_36">M5: &#160;</span></div>
<div style="position:absolute; top:57.2296em; left:15.492em;"><span class="stl_568 stl_07 stl_73">9</span></div>
<div style="position:absolute; top:57.3277em; left:6.75em;"><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0833em;">of blasts</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0523em;"> in excess of</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0833em;"> 80x10</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.4397em;"> cells/L</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0533em;"> is a</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0113em;"> worrisome</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0533em;"> sign</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0533em;"> and &#160;</span></div>
<div style="position:absolute; top:57.3197em; left:28em;"><span class="stl_567 stl_169 stl_36">M6: &#160;</span></div>
<div style="position:absolute; top:57.3197em; left:31.286em;"><span class="stl_567 stl_169 stl_38" style="word-spacing:-0.0767em;">Acute erythroleukemia (or erythroblastic) leukemia &#160;</span></div>
<div style="position:absolute; top:58.3198em; left:31.2867em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">(Plates 51- 53) &#160;</span></div>
<div style="position:absolute; top:58.3329em; left:6.7503em;"><span class="stl_550 stl_07 stl_125" style="word-spacing:0.1281em;">warrants prophylaxis for tumor lysis syndrome and meas- &#160;</span></div>
<div style="position:absolute; top:59.3325em; left:6.7503em;"><span class="stl_550 stl_07 stl_19" style="word-spacing:0.1616em;">ures to reduce the blast load.</span><span class="stl_550 stl_07 stl_19" style="word-spacing:0.0966em;"> Very</span><span class="stl_550 stl_07 stl_19" style="word-spacing:0.1616em;"> low</span><span class="stl_550 stl_07 stl_19" style="word-spacing:0.0186em;"> white</span><span class="stl_550 stl_07 stl_19" style="word-spacing:0.1616em;"> cell count</span><span class="stl_550 stl_07 stl_19" style="word-spacing:0.1616em;"> is &#160;</span></div>
<div style="position:absolute; top:60.3321em; left:6.7503em;"><span class="stl_550 stl_07 stl_87" style="word-spacing:-0.006em;">seen in 25-35% of</span><span class="stl_550 stl_07 stl_87" style="word-spacing:0.023em;"> patients</span><span class="stl_550 stl_07 stl_87" style="word-spacing:-0.0141em;"> with AML, and pancytopenia is</span><span class="stl_550 stl_07 stl_87" style="word-spacing:-0.0141em;"> a &#160;</span></div>
<div style="position:absolute; top:61.3317em; left:6.7503em;"><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0255em;">common presenting feature of</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0545em;"> this</span><span class="stl_550 stl_07 stl_219" style="word-spacing:0.0255em;"> disease. &#160;</span></div>
<div style="position:absolute; top:59.4865em; left:28em;"><span class="stl_567 stl_169 stl_36">M7: &#160;</span></div>
<div style="position:absolute; top:59.4865em; left:31.286em;"><span class="stl_567 stl_169 stl_38" style="word-spacing:-0.0766em;">Acute megakaryocytic (or megakaryoblastic) leukemia &#160;</span></div>
<div style="position:absolute; top:60.4866em; left:31.2867em;"><span class="stl_567 stl_169 stl_36" style="word-spacing:-0.075em;">(Plates 54, 55) &#160;</span></div>
<div style="position:absolute; top:64.0452em; left:3.75em;"><span class="stl_569 stl_89 stl_90">30 &#160;</span></div>
</div>
</div>
</div>
</body>
</html>
